{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:16:07Z","timestamp":1761743767583},"reference-count":24,"publisher":"Pharmaceutical Society of Japan","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2013]]},"DOI":"10.1248\/bpb.b13-00234","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T22:56:39Z","timestamp":1368572199000},"page":"1221-1225","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness of Sirolimus in Combination with Cyclosporine against Chronic Rejection in a Pediatric Liver Transplant Patient"],"prefix":"10.1248","volume":"36","author":[{"given":"Haruka","family":"Shinke","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiyo","family":"Hashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Kinoshita","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Risa","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuhiro","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Matsubara","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eri","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narito","family":"Takada","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Yoshizawa","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Uemoto","sequence":"additional","affiliation":[{"name":"Divisions of Hepato-Pancreato-Biliary, Transplant and Pediatric Surgery, Department of Surgery, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satohiro","family":"Masuda","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Faculty of Medicine, Kyoto University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Darbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. <i>Hepatology<\/i>, 38, 560\u2013566 (2003).","DOI":"10.1053\/jhep.2003.50375"},{"key":"2","unstructured":"2) Van Tornout JM, Buckley JD, Quinn JJ, Feusner JH, Krailo MD, King DR, Hammond GD, Ortega JA. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children\u2019s Cancer Group. <i>J. Clin. Oncol.<\/i>, 15, 1190\u20131197 (1997)."},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1007\/s00383-010-2708-0"},{"key":"4","unstructured":"4) Lieber J, Ellerkamp V, Wenz J, Kirchner B, Warmann SW, Fuchs J, Armeanu-Ebinger S. Apoptosis sensitizers enhance cytotoxicity in hepatoblastoma cells. <i>Pediatr. Surg. Int.<\/i>, 28, 149\u2013159 (2012)."},{"key":"5","unstructured":"5) Koneru B, Flye MW, Busuttil RW, Shaw BW, Lorber MI, Emond JC, Kalayoglu M, Freese DK, Starzl TE. Liver transplantation for hepatoblastoma. The American experience. <i>Ann. Surg.<\/i>, 213, 118\u2013121 (1991)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Otte JB, Pritchard J, Aronson DC, Brown J, Czauderna P, Maibach R, Perilongo G, Shafford E, Plaschkes J, International Society of Pediatric Oncology (SIOP). Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. <i>Pediatr. Blood Cancer<\/i>, 42, 74\u201383 (2004).","DOI":"10.1002\/pbc.10376"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1038\/352803a0"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1006\/cimm.1994.1193"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of <i>de novo<\/i> malignancies. <i>Transplantation<\/i>, 80, 883\u2013889 (2005).","DOI":"10.1097\/01.TP.0000184006.43152.8D"},{"key":"10","unstructured":"10) Atkins MB, Hidalgo M, Stadler WM, Logan TF, Dutcher JP, Hudes GR, Park Y, Liou SH, Marshall B, Boni JP, Dukart G, Sherman ML. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma. <i>J. Clin. Oncol.<\/i>, 22, 909\u2013918 (2004)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Gr\u00fcnwald V, Thompson JA, Figlin RA, Hollaender N, Urbanowitz G, Berg WJ, Kay A, Lebwohl D, Ravaud A, RECORD-1 Study Group. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. <i>Lancet<\/i>, 372, 449\u2013456 (2008).","DOI":"10.1016\/S0140-6736(08)61039-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Elsharkawi M, Staib L, Henne-Bruns D, Mayer J. Complete remission of posttransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil. <i>Transplantation<\/i>, 79, 855\u2013857 (2005).","DOI":"10.1097\/01.TP.0000154913.88193.FF"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.23.9231"},{"key":"14","unstructured":"14) Nielsen D, Briem-Richter A, Sornsakrin M, Fischer L, Nashan B, Ganschow R. The use of everolimus in pediatric liver transplant recipients: first experience in a single center. <i>Pediatr. Transplant.<\/i>, 15, 510\u2013514 (2011)."},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2010.07.031"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201041336"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287821"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kahan BD. The potential role of rapamycin in pediatric transplantation as observed from adult studies. <i>Pediatr. Transplant.<\/i>, 3, 175\u2013180 (1999).","DOI":"10.1034\/j.1399-3046.1999.00036.x"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200005270-00019"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66383-0"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.2133\/dmpk.21.492"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200002000-00006"},{"key":"23","unstructured":"23) Haehner T, Refaie MO, M\u00fcller-Enoch D. Drug\u2013drug interactions evaluated by a highly active reconstituted native human cytochrome P4503A4 and human NADPH-cytochrome P450 reductase system. <i>Arzneimittelforschung<\/i>, 54, 78\u201383 (2004)."},{"key":"24","unstructured":"24) Wagner F, Henningsen B, Lederer C, Eichenm\u00fcller M, G\u00f6deke J, M\u00fcller-H\u00f6cker J, von Schweinitz D, Kappler R. Rapamycin blocks hepatoblastoma growth <i>in vitro<\/i> and <i>in vivo<\/i> implicating new treatment options in high-risk patients. <i>Eur. J. Cancer<\/i>, 48, 2442\u20132450 (2012)."}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/7\/36_b13-00234\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T05:19:19Z","timestamp":1615871959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/36\/7\/36_b13-00234\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b13-00234","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}